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Introduction
Sensitivity and resistance to apoptosis are to a large degree reg-
ulated by pro- and anti-apoptotic members of the Bcl-2 protein 
family. How this regulation is achieved is under intense investi-
gation (Adams, 2003; Danial and Korsmeyer, 2004). Structural 
and functional similarities divide the Bcl-2 family into three 
groups. The pro-apoptotic multidomain proteins (containing the 
Bcl-2 homology [BH] domains 1–3) Bax and/or Bak are required 
for mitochondrial permeabilization during apoptosis (Lindsten 
et al., 2000; Zong et al., 2001; Adams, 2003; Danial and  Korsmeyer, 
2004). The activation of Bax/Bak is caused consecutively to 
the activation of the BH3-only group of Bcl-2 family proteins 
(which have in common only the short BH3 domain; Huang 
and Strasser, 2000; Puthalakath and Strasser, 2002). The anti-
apoptotic group of Bcl-2 proteins contains Bcl-2, Bcl-xL, Bcl-w, 
Mcl-1, and A1 (Cory and Adams, 2002).
The various interactions between these proteins are crucial 
for the life-death decision. However, many details of these inter-
actions are still unclear. Direct binding of Bax to Bcl-2 was 
demonstrated early on (Oltvai et al., 1993), but the signifi  cance 
of this interaction is questionable because it depends on the 
presence of certain detergents (Hsu and Youle, 1997) and be-
cause Bcl-2 is localized on intracellular membranes, whereas 
Bax is largely soluble in the cytosol (Suzuki et al., 2000; Schinzel 
et al., 2004). Bak, on the other hand, is an integral protein of the 
outer mitochondrial membrane, and it has recently been demon-
strated to be sequestered there and kept inactive by the two anti-
apoptotic Bcl-2 proteins, Mcl-1 and Bcl-xL (Willis et al., 2005).
Eight BH3-only proteins are known. It is fi  rmly estab-
lished that their BH3 domains can bind to anti-apoptotic Bcl-2 
proteins, which prevents their activating Bax/Bak (Petros et al., 
2000; Liu et al., 2003; Chen et al., 2005). This has led to the 
proposition that BH3-only proteins induce apoptosis, at least 
in part, through the neutralization of Bcl-2-like proteins. This 
view has gained support by the recent demonstration of a selec-
tivity in binding between BH3-only proteins and Bcl-2-like 
proteins (Chen et al., 2005), reproduced in another study using 
a different technical approach (Certo et al., 2006). Although 
both studies are potentially limited by the use of BH3 domain 
peptides rather than whole proteins, the results are intriguing. 
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  R
elease of apoptogenic proteins such as cytochrome c 
from mitochondria is regulated by pro- and anti-
apoptotic Bcl-2 family proteins, with pro-apoptotic 
BH3-only proteins activating Bax and Bak. Current mod-
els assume that apoptosis induction occurs via the bind-
ing and inactivation of anti-apoptotic Bcl-2 proteins by 
BH3-only proteins or by direct binding to Bax. Here, we 
analyze apoptosis induction by the BH3-only protein 
BimS. Regulated expression of BimS in epithelial cells 
was followed by its rapid mitochondrial translocation 
and   mitochondrial membrane insertion in the absence of 
detectable binding to anti-apoptotic Bcl-2 proteins. This 
caused mitochondrial recruitment and activation of Bax 
and apoptosis. Mutational analysis of BimS showed that 
mitochondrial targeting, but not binding to Bcl-2 or Mcl-1, 
was required for apoptosis induction. In yeast, BimS 
  enhanced the killing activity of Bax in the absence of 
anti-apoptotic Bcl-2 proteins. Thus, cell death induction 
by a BH3-only protein can occur through a process that 
is independent of anti-apoptotic Bcl-2 proteins but requires 
mitochondrial targeting.
Correspondence to Georg Häcker: hacker@lrz.tum.de
Abbreviations used in this paper: BH, Bcl-2 homology; IP, immunoprecipitation; 
tet, tetracycline.
The online version of this article contains supplemental material.JCB • VOLUME 177 • NUMBER 4 • 2007  626
The selectivity of binding found in these studies could explain 
the varying apoptosis-inducing potency of BH3-only proteins, 
and the model has been elegantly confi  rmed by the demonstra-
tion that combining BH3-only proteins that can bind to Bcl-xL 
and Mcl-1 leads to the release and, presumably, the auto-activation 
of Bak (Willis et al., 2005).
The above studies have engendered two models of BH3- 
only protein action. One model (the direct binding model) pro-
poses that the BH3-only proteins Bim and tBid (and perhaps 
Puma) can directly bind and activate Bax/Bak (Letai et al., 
2002; Certo et al., 2006), whereas the remaining BH3-only pro-
teins (Bik, Puma, Noxa, Bad, Bmf, and Hrk) can only sensitize, 
i.e., release Bim and tBid from their site of sequestration to Bcl-
2-like proteins (and Bim/tBid would then go on to activate Bax/
Bak). Although it is diffi  cult to demonstrate the interaction of 
Bim/tBid with Bax/Bak in intact cells, this model has received 
support from studies with purifi  ed proteins and artifi  cial mem-
branes (Kuwana et al., 2002, 2005).
The second model (the displacement model) proposes that 
Bax/Bak can auto-activate once the inhibition imposed by Bcl-2-
like proteins has been removed by BH3-only proteins, but that 
no direct interaction between BH3-only proteins and Bax/
Bak is required (Chen et al., 2005; Willis and Adams, 2005). 
Although this model has been supported experimentally for Bak 
(see above), it is still diffi  cult to see how this mechanism could 
work for Bax. One step in the activation of Bax has to be the 
mitochondrial translocation. Although this Bax translocation 
and insertion is seen during apoptosis induction (Gross et al., 
1998; Eskes et al., 2000), there is no signal known that could 
initiate this, and no interaction partner is known that could 
  determine Bax translocation.
BH3-only proteins are activated upon apoptotic stimuli 
from the outside. However, the study of BH3-only protein action 
in intact cells is not easy. One problem is that most BH3-only 
proteins are subject to post-translational regulation, and their 
activation and activity are very diffi  cult to measure. For  instance, 
Bim is expressed in normal cells and is activated upon a suitable 
stimulus, but is it unclear how Bim is activated on a molecular 
level. Furthermore, apoptotic stimuli may activate more than 
one BH3-only protein, and this may depend on the cell type 
used. Lastly, most apoptotic stimuli have massive side effects. 
UV   irradiation, for instance, will activate BH3-only proteins 
in many cells but also activate other pathways, such as stress 
  kinases and the DNA-damage response, confounding the ob-
served results.
To escape these problems and to analyze the consequences 
of BH3-only protein activation in human cells, we used a strat-
egy of inducible expression of Bim in HeLa epithelial cells. 
The inducible expression of BimS was suffi  cient to induce apop-
tosis. This enabled us to investigate the interaction of BimS with 
other Bcl-2 proteins and the events triggered by BimS at the 
cell’s mitochondria.
Results
We fi rst tested the major isoform of Bim, BimEL. In transient 
transfection experiments of T-REx-HeLa cells (a cell line stably 
carrying the tetracycline repressor, in which expression of the 
construct is induced by tetracycline [tet]) BimEL induced apopto-
sis of transfected cells ( 50% dead cells after 24 h in the pres-
ence of tet). Upon transfection and selection, nine clones were 
obtained that stably carried the tet-inducible BimEL construct. All 
of these clones expressed BimEL, and the expression was induced 
to varying degrees by tet addition. The expression exceeded 
in all clones by far the endogenous levels in T-REx-HeLa cells, 
which is easily detectable by Western blotting (unpublished data). 
Figure 1.  Interaction between BimS and 
prosurvival proteins as tested by immuno-
precipitation. BimS-expressing clone A2 (a, c, 
and d) or T-Rex-293 cells transiently trans-
fected with the BimS construct (b) were left 
untreated or treated with tetracycline for 6 h 
(A2 clone) or 16 h (T-Rex-293 cells). Mito-
chondrial lysates (a–c) or whole-cell lysates 
(d) were immunoprecipitated with anti-Bim 
antibodies. Aliquots of mitochondrial (L, 45 μg 
of protein) or total cell lysates (L, 22 μg), 
post-IP supernatant (SN), and IP pellets (IP) 
were loaded and membranes were probed 
for Bim, Bcl-2, Mcl-1, Bcl-w, A1, and Bcl-xL. 
The migration of immunoglobulin light chain 
(Ig) is indicated but was not observed in all 
experiments. (c) Left, pellet fractions after 
Bim-IP from isolated mitochondria (ﬁ  rst lane), 
cytosolic fraction (middle lane) after 4 h of 
tet and from mitochondria without tet (third 
lane). Right, speciﬁ   city control with anti-
bodies against an unrelated protein (mBmf). 
(d) Binding of tet-induced BimS to transiently 
expressed Bcl-2. Cells were transfected with 
control vector or an expression vector for human 
Bcl-2, lysed, and Bim was immunoprecipitated 
as above. Bim and Bcl-2 were detected by 
Western blotting. All Western blots are repre-
sentative of three independent experiments (the 
experiment shown in panel d was done twice).MITOCHONDRIAL IMPORT OF BIM • WEBER ET AL. 627
However, tet-induced expression of BimEL completely failed to 
induce apoptosis in these cells (unpublished data).
Although this was unexpected, it might be explained by 
the fact that BimEL is in many cells expressed at relatively high 
levels and is probably activated by molecular events that have 
not been fully worked out. We thus turned to the expression 
of BimS (mouse BimS was used, as at the time the identity of 
 human  BimS was not unequivocal in the databases). BimS is the 
shortest of the regularly expressed Bim isoforms, is normally 
expressed at very low levels, and is not subject to any known 
post-translational activation (O’Connor et al., 1998;  Puthalakath 
et al., 1999). When expressed transiently as above, BimS was 
more active than BimEL ( 80% dead cells at 24 h), confi  rming 
earlier results (O’Connor et al., 1998). Two stable cell lines 
carrying the inducible BimS construct were analyzed in detail. 
There was no major difference in the parameters analyzed be-
tween these two lines.
In these clones, tet addition induced apoptosis in a dose-
dependent manner (Fig. S1 a, available at http://www.jcb.org/
cgi/content/full/jcb.200610148/DC1). Cell death was rapid, 
with  50% of cells containing active caspase-3 after 2 h (Fig. 
S1 b) and  90% of cells containing condensed nuclei after 4–6 h 
(not depicted). We then proceeded to analyze the molecular 
events during apoptosis induction by BimS. Both models of 
BH3-only protein action, especially the displacement model, 
predict that BimS will induce apoptosis through binding to anti-
apoptotic Bcl-2 proteins. We therefore tested the association of 
BimS with Bcl-2 by immunoprecipitation (IP). IP with anti-
bodies specifi  c for Bim precipitated BimS from both clones 
(Fig. 1 a and Fig. S3 a). A fraction of Bcl-2, Mcl-1, and Bcl-xL 
was coprecipitated with Bim from uninduced cells (Fig. 1, a and c), 
suggesting that the “leaky” BimS that was expressed in these 
cells was associated with Bcl-2, Mcl-1, and Bcl-xL (see Fig. 1 c 
for a specifi  city control). Induction with tet led to the increase in 
the amount of BimS isolated (Fig. 1 a). However, the amount of 
Bcl-2, Mcl-1, and Bcl-xL coprecipitated with BimS appeared to 
be essentially the same as in uninduced cells, suggesting that 
the induced, apoptosis-inducing fraction of BimS is not bound 
to Bcl-2, Mcl-1, or Bcl-xL. Although Bcl-w and A1 were detect-
able in the cells by Western blotting, they were not seen in IP 
products, suggesting that none or very little of these proteins 
was bound to BimS (Fig. 1 a). These results indicate that, in or-
der to induce apoptosis, BimS does not need to bind to detect-
able amounts of anti-apoptotic Bcl-2 proteins in HeLa cells. 
To test this in a different cellular system, 293 human fi  broblasts 
carrying the tet repressor (T-REx-293 cells) were transiently 
transfected with the BimS construct, and binding of BimS to 
Bcl-2 family proteins was tested. As in the case of HeLa cells, 
small amounts of Bcl-2 and Mcl-1 could be coprecipitated with 
BimS, and a very faint band was seen when probing for Bcl-w 
(Bcl-xL was undetectable in these cells). However, as in the 
HeLa clones, the amounts precipitated appeared essentially 
the same when BimS expression was induced by tet (Fig. 1 b). 
  Notably, we could detect some Bax by co-IP in these experiments, 
when higher amounts of mitochondria were used or when mito-
chondria or whole-cell lysates were used from the T-REx-293 
cells transiently transfected with the BimS construct (see Fig. 
S3, b–d). Weak binding of BimS (unlike BimEL or BimL) to Bax 
in detergent lysates has been observed before but was found not 
to be required for apoptosis induction, as a BimS mutant that 
had lost this binding capacity still induced apoptosis equally 
well (Marani et al., 2002; Willis et al., 2007).
Figure 2.  BimS localizes to and inserts into 
mitochondrial membranes in HeLa cells and in 
isolated mitochondria. (a) Mitochondria (m) 
from T-REx-HeLa cells (A2 clone) uninduced or 
tet-induced as indicated were isolated and 
separated alongside the soluble cytosolic frac-
tions (c) on 12.5% SDS-PAA gels. CoxIV is a 
marker for mitochondria, caspase-8 for cyto-
solic proteins. (b) Isolated mitochondria were 
treated with 0.1 M Na2CO3 to separate 
membrane inserted (Ins.) from soluble (Att., 
membrane attached, intermembrane space 
and matrix) fractions. Both fractions were ana-
lyzed by Western blotting for Bim, CoxIV as a 
marker for mitochondrial membranes and Bax. 
(c) Import of in vitro–translated BimEL or BimS 
into isolated HeLa mitochondria. Radiolabeled 
precursors of BimEL and BimS were incubated 
for 10 and 30 min at 30°C with mitochondria 
isolated from HeLa cells. Subsequently, the 
samples were split. One third was treated with 
50 μg/ml proteinase K (PK) for 20 min on ice, 
another one was left untreated. The last third 
was subjected to alkaline extraction resulting 
in a pellet fraction (P; containing integral mem-
brane proteins) and a supernatant fraction 
(S; containing soluble and peripherally at-
tached proteins). For comparison, 10% of the 
total input of radiolabeled precursors was in-
cluded (T). Mitochondria were reisolated and 
import was analyzed by SDS-PAGE and auto-
radiography. *, very likely proteolysis products.JCB • VOLUME 177 • NUMBER 4 • 2007  628
As an additional control, BimS cells were transiently 
transfected with an expression construct for Bcl-2. As expected, 
the transfected cells were protected against BimS-induced 
apoptosis (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200610148/DC1). However, in cells overexpressing 
Bcl-2, tet-induced BimS clearly associated with Bcl-2 as judged 
by the increased amount of Bcl-2 coprecipitated with BimS 
(Fig. 1 d, compare lanes where the IP pellet was loaded). This 
indicates that in the situation where Bcl-2 acts to block BimS-
induced apoptosis, it does so via direct binding of BimS. Con-
versely, when the apoptosis-inducing activity of BimS is not 
blocked, no binding between BimS and anti-apoptotic Bcl-2 
proteins can be detected.
In the attempt to understand the molecular function of 
BimS we next analyzed the subcellular localization of induced 
BimS. In uninduced cells, a small amount of BimS was detect-
able in the fraction containing mitochondria. Tet-induced BimS 
was initially also found in mitochondria, and only when higher 
levels were reached (especially in the 3C4 clone) part of it was 
seen in the cytosol (Fig. 2 a and Fig. S4, respectively, for the two 
clones tested; there was some difference between the clones 
as to localization, which may be linked to different amounts 
of BimS induced or possibly to different mitochondrial import 
capacity [see below]). Intriguingly, mitochondrial BimS was 
  integrally inserted into mitochondrial membranes, as measured 
by alkaline treatment of mitochondria (which allows separation of 
integral membrane proteins from soluble/peripherally attached 
proteins; Fig. 2 b). Some (endogenous) BimEL was also found 
expressed in mitochondria, possibly a fraction that had been ac-
tivated but blocked by anti-apoptotic proteins. BimEL was also 
inserted into mitochondrial membranes, as was Bax (Fig. 2 b). 
In vitro import experiments using radiolabeled Bim proteins 
confi  rmed these results. Both in vitro–translated BimEL and BimS 
proteins became associated with isolated HeLa mitochondria 
upon incubation in a typical mitochondrial   import reaction 
(Fig. 2 c). When mitochondria were then treated with protease 
the Bim proteins were readily digested, suggesting an exposed 
localization at the outer membrane of mitochondria. Alkaline ex-
traction experiments following the import experiments indicate 
that Bim was integrally inserted into mitochondrial membranes 
(Fig. 2 c). Similar results were obtained when yeast mitochon-
dria (from Saccharomyces cerevisiae) were used (not depicted).
The exposed localization and the membrane integration 
of Bim imply that Bim is integrally inserted into the mitochon-
drial outer membrane, suggesting that it translocates to the sur-
face of the mitochondria (most likely directed by an intrinsic 
mitochondrial targeting signal), where it is inserted into the 
lipid bilayer of the outer membrane through the activity of the 
TOM complex (the general translocase of the mitochondrial 
outer membrane). Bim thus seems to follow the main import 
pathway for mitochondrial outer membrane proteins (Paschen 
and Neupert, 2001).
We noticed in these experiments that the expression of 
BimS caused an early shift of Bax to mitochondria. This was de-
tectable as both an increase in mitochondrial Bax and, perhaps 
more distinctly, a cytosolic depletion of Bax that was clearly vis-
ible a few hours after BimS induction (Fig. 2 a and Fig. S4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200610148/DC1). 
Similar results were obtained when T-REx-293 cells were tran-
siently transfected with wild-type BimS construct and induced 
with tet. No translocation of Bax to the mitochondria was seen 
when the empty expression vector was used (unpublished data).
Figure 3.  BimS-expression causes Bax oligomeriza-
tion and mitochondrial recruitment of Bax. (a) BimS 
was induced in HeLa cells (A2 clone) as indicated for 
6 h. Mitochondria were isolated and treated with 
two different cross-linkers as described in Materials 
and Methods. After cross-linking, the reaction was 
analyzed by Western blotting with an anti-Bax mono-
clonal antibody. (b) BimS cells (A2 clone) were tran-
siently transfected with the EGFP-Bax fusion construct 
and were analyzed by confocal microscopy   untreated 
(top) or upon BimS-induction (bottom, 5 h). Localization 
of EGFP-Bax (green), mitochondria (red), BimS (blue), 
and various overlays are shown. Bars, 10 μm.MITOCHONDRIAL IMPORT OF BIM • WEBER ET AL. 629
The activation of Bax has been measured by a conforma-
tional change at the N terminus (Hsu and Youle, 1997) or the 
C-terminal part (Dewson et al., 2003), or as oligomerization at 
mitochondria (Eskes et al., 2000). Bands corresponding to the 
described Bax dimers and trimers were found when mitochon-
drial proteins were cross-linked upon BimS induction (Fig. 3 a). 
Bax activation as measured by staining for N- or C-terminal 
conformational change was also detected (not depicted).
In order better to visualize mitochondrial translocation of 
Bax, we used an EGFP-Bax fusion protein that has been de-
scribed before to translocate to mitochondria during apoptosis 
(Schinzel et al., 2004). Laser-scanning microscopy confi  rmed 
that tet-induced BimS was predominantly located on the cell’s 
mitochondria (Fig. 3 b). Upon transient transfection EGFP-Bax 
was localized in the cytosol, but upon induction of BimS trans-
located to the mitochondria where it colocalized with BimS 
(Fig. 3 b). It is worth noting that mitochondrial Bax at all times 
appeared to be inserted into mitochondrial membranes rather 
than be loosely attached (Fig. 2 b). Thus, the sole manipulation 
of tet-dependent induction of BimS causes the translocation of 
Bax to mitochondria, accompanied by Bax activation.
These results suggested that the mitochondrial transloca-
tion, but not the interaction with anti-apoptotic Bcl-2 proteins, 
was the key event in apoptosis induction by BimS. We therefore 
pursued the two-pronged strategy of analyzing BimS mutants 
that were engineered to differ either in translocation or in their 
capacity to interact with Bcl-2. Fig. 4 gives a schematic repre-
sentation of the mutants used.
It has been noted before that the C terminus of Bim (which 
is part of the protein in all major splice forms) contains a poten-
tial membrane insertion sequence, and it has been shown early 
on that overexpressed Bim is targeted to intracellular mem-
branes (O’Connor et al., 1998). Further, our above data suggest 
that active Bim is a tail-anchored protein, which is targeted to 
mitochondria through this hydrophobic C-terminal domain (see 
Fig. 2). To analyze the role of mitochondrial translocation of 
BimS, three mutants were generated. The fi  rst one, BimS(1–88), 
was generated by introducing a stop codon after amino acid 
88, deleting the hydrophobic C terminus. The second mutant 
(BimSTom5) was engineered to consist of the amino acids 1–84 
of BimS followed by the mitochondrial tail-anchor sequence 
of yeast Tom5 (which is imported into the outer mitochondrial 
membrane), a well-investigated member of the mitochondrial 
outer membrane protein translocation complex (Horie et al., 
2003). The third mutant (BimS∆∆Tom5) differed from the sec-
ond by the deletion of two amino acid residues in the BH3 do-
main predicted to abolish its pro-apoptotic activity (Fig. 4).
Localization of the mutants in transient transfection of 
T-REx-293 cells was as predicted (Fig. 5 a): BimS(1–88) was 
detected almost exclusively in the cytosol, whereas BimSTom5 
was mostly found on mitochondria. The majority of BimS∆∆Tom5 
was mitochondrial with a cytosolic fraction, possibly an over-
fl  ow from mitochondria as this mutant was expressed at higher 
levels. BimS∆∆ (full-length BimS containing the BH3 domain 
double deletion, Fig. 4) was also targeted to mitochondria, 
as was BimS(D69A). Co-expression of Bcl-2 failed to direct 
BimS(1–88) to mitochondria (Fig. 5 a). Laser-scanning micros-
copy was used to confi  rm these results with respect to BimS, 
BimS(1–88), and BimSTom5 (Fig. 5 b). The apoptosis-inducing 
activity of the mutants was tested by transient transfection of 
T-REx-293 cells, where the expression was regulated by tet. As 
shown in Fig. 5 c, BimS(1–88) had completely lost its apoptosis 
inducing activity, while retargeting of this mutant by a mito-
chondrial targeting sequence (BimSTom5) restored this activity 
not completely but to a substantial degree. The BH3 domain de-
letion (BimS∆∆Tom5) again almost abolished it (Fig. 5 c shows 
the results for caspase-3 activation; similar results were seen 
when apoptotic morphology was assessed [Fig. S5 a, available 
at http://www.jcb.org/cgi/content/full/jcb.200610148/DC1]). 
Therefore, mitochondrial targeting and an intact BH3 domain 
are required for apoptosis induction by BimS in this system.
In the second line of experiments, mutations were made to 
the BH3 domain of BimS and their effect on binding to Bcl-2 
and on apoptosis induction was tested. The double deletion 
mentioned above and three point mutations were introduced in 
BimS (Fig. 4). When binding to Bcl-2 was tested by cotransfec-
tion of Bcl-2 and the respective BimS mutant into T-REx-293 
cells, interaction with Bcl-2 (measured by co-IP) was seen for 
Figure 4.  Schematic representation of BimS and BimS mutant proteins used in this study. Mutants were generated that lack the hydrophobic C terminus 
(1–88, bottom) or where the C terminus was replaced with the mitochondrial membrane anchor of yeast Tom5 (BimSTom5, middle) or that contain various 
mutations in the BH3 domain as indicated in the box.JCB • VOLUME 177 • NUMBER 4 • 2007  630
BimS wild type, BimSTom5 and, albeit to a lesser extent, 
BimS(1–88) and BimS(R66E). It has to be pointed out that this 
assay only tests for interaction capacity and not actual interaction. 
BimS(1–88) is almost exclusively located in the cytosol, while 
Bcl-2 is membrane associated (compare Fig. 1 c with Fig. 5 a), 
so the co-IP very likely relies on an interaction enabled only 
upon detergent solubilization. No binding to Bcl- 2 was detected 
for the mutants BimS∆∆, BimS∆∆Tom5, BimS(D69A), and 
BimS(L64A) (Fig. 6 a). BimS∆∆ and the point mutants showed 
almost no apoptosis inducing activity in this assay except for 
BimS(D69A), which conserved over half of the apoptosis induc-
ing activity (Fig. 6 c and Fig. S5 b). This group of mutants 
therefore contains two examples that did not show correlation 
between Bcl-2 binding and apoptosis induction predicted by the 
displacement model. BimS(R66E) shows considerable binding 
to overexpressed Bcl-2 (Fig. 6 a) but fails to induce apoptosis, 
while BimS(D69A) fails to bind to Bcl-2 but has considerable 
apoptosis-inducing activity. When the mutant was expressed in 
T-Rex-293 cells, BimS(D69A)-IP brought down a small amount 
of endogenous Mcl-1. However, this amount was essentially the 
same when Mcl-1 was overexpressed (Fig. 6 b). This suggests 
that the small amount of coprecipitated Mcl-1 was bound to 
 endogenous  BimEL, which is also found in mitochondria and 
cannot be separated in this assay (see Fig. 2 b). The binding of 
Figure 5.  Subcellular localization of BimS mutants and 
their pro-apoptotic activity. (a) Localization as determined 
by cell fractionation. T-REx-293 cells were transiently 
transfected with wild-type or mutant constructs and in-
duced 7 h later with tet for  15 h. Mitochondria (m) and 
cytosolic fractions (c) were prepared and tested for ex-
pression of BimS proteins. As a control (ct) the cells were 
transfected with the empty expression vector. BimS(1–88)/
Bcl-2: cells were cotransfected with BimS(1–88) and an 
expression construct for hBcl-2. The mutants are described 
in Fig. 4. (b) Localization of C-terminal mutants as deter-
mined by confocal microscopy. Cells were transfected as 
above, induced 24 h later for 5 h with tet, and BimS was 
detected by staining with Bim-speciﬁ  c antibodies. Mito-
chondria were identiﬁ  ed by MitoTracker staining. Bars, 
10 μm. (c) T-Rex-293 cells were transiently transfected 
with the constructs indicated (ct, empty vector control). 
7 h later, expression of BimS was induced by tet addition 
as shown. 15 h later, cells were harvested and percent-
age of active caspase-3–positive cells was determined by 
ﬂ   ow cytometry. Black bars indicate induction with tet; 
white bars without tet. The values give the mean of at 
least three independent experiments/SEM. Expression of 
transfected proteins was conﬁ  rmed by Western blotting 
(not depicted).MITOCHONDRIAL IMPORT OF BIM • WEBER ET AL. 631
BimS(D69A) to Mcl-1 is thus either abolished or at least very 
strongly reduced. As predicted by all models from the lack of 
binding, Bcl-2 was unable to protect TRex HeLa cells against 
the overexpression of BimS(D69A) in transient transfection as-
says, although it protected against BimS-induced apoptosis (not 
depicted). Notably, although BimS was found to bind to Bax, 
BimS(D69A) failed to do so when whole-cell lysates of T-REx-
293 cells transiently transfected with the BimS mutant construct 
were used for Bim-IP (see Fig. S3 d). A summary of the results 
is given in Table I.
These results suggested that mitochondrial targeting rather 
than binding to anti-apoptotic Bcl-2 proteins was the determi-
nant of apoptosis induction through BimS. To test this hypothesis 
in an independent system, we turned to the yeast S. cerevisiae. 
Although it is a matter of dispute whether yeast possesses a sys-
tem for apoptotic response (Frohlich and Madeo, 2000; Wysocki 
and Kron, 2004), it is clear that the expression of Bax can kill 
yeast cells (Sato et al., 1994), which can be detected by growth 
arrest and which is accompanied by mitochondrial hyperpolar-
ization (Gross et al., 2000). Notably, yeast has no recognized 
Bcl-2 family proteins. We therefore examined whether BimS 
would enhance Bax-dependent killing in yeast (which would 
have to occur in the absence of anti-apoptotic Bcl-2 proteins). 
BimS was expressed from a constitutive promoter and Bax was 
placed under the control of the tet-off system (i.e., Bax was ex-
pressed in the absence of tet).
Yeast cells tolerated the expression of BimS without any 
growth delay or other detectable alteration, and no effect was 
seen in cells that carried the (switched-off) inducible Bax plas-
mid in the presence of tet (Fig. 7). At 48 h after removal of tet 
from the liquid culture, there was a clear reduction in growth that 
was the same in cells that expressed Bax and in cells that ex-
pressed BimS and Bax (Fig. 7 b). No further growth was observed 
in these cells at later time points (not depicted). When cell den-
sity was measured at earlier times, we noted that although Bax 
expression on its own had no signifi  cant growth-delaying effect 
at 24–30 h (P = 0.511; Bax vs. wt), there was a clear and signifi  -
cant reduction of cell growth at this point when BimS and Bax 
were coexpressed (Fig. 7 a; (P = 0.002, BimS + Bax vs. wt). 
This suggested that the expression of BimS, although not affecting 
Figure 6.  Bcl-2/Mcl-1 binding and pro-apoptotic activity of BH3 
domain mutants of BimS. T-REx-293 cells were transfected with the 
mutants indicated (see Fig. 4) together with an expression con-
struct for hBcl-2 (a) or alone (c). After 7 h, BimS was induced with tet. 
(a) 18 h later Bim was immunoprecipitated from whole-cell 
extracts (200 μg) of T-REx-293 cells as above. Control (ct), cells 
were transfected with hBcl-2 vector and the empty expression 
vector instead of a BimS expression vector. (b) T-REx-293 cells 
were cotransfected with hMcl-1 vector and the wild-type BimS or the 
mutant construct BimS(D69A). 18 h later Bim was immunoprecipi-
tated from whole-cell extracts (200 μg left, 300 μg middle and 
right) as above. Two experiments are shown. Right: same experi-
ment showing binding of endogenous Mcl-1 to Bim where cells 
were solely transfected with wt BimS or the mutant construct 
BimS(D69A). (c) 15 h later cells positive for active caspase-3 were 
scored by ﬂ  ow cytometry after staining with a monoclonal anti-
body against active caspase-3 and a Cy3-conjugated secondary 
antibody. Values give mean of at least three independent experi-
ments/SEM. Expression of transfected proteins was conﬁ  rmed by 
Western blotting (not depicted).JCB • VOLUME 177 • NUMBER 4 • 2007  632
growth on its own, accelerated the growth inhibition conferred 
by Bax. Notably, the expression of BimS(1–88) or BimS∆∆ 
  together with Bax failed to enhance the Bax effect (unpub-
lished data).
A similar acceleration/enhancement was seen when yeast 
were assayed for the second criterion, i.e., mitochondrial mem-
brane potential. No change in uptake of the potential-sensitive 
dye rhodamine123 was seen due to the expression of BimS or in 
yeast carrying the uninduced Bax construct (Fig. 8, a and b, and 
unpublished data). Induction of Bax caused a partial shift of 
the population to higher fl  uorescence, as described previously 
(Gross et al., 2000), indicative of mitochondrial hyperpolariza-
tion. When Bax was induced in BimS-expressing cells this shift 
was more pronounced, suggesting that BimS either increased 
the population of yeast cells with hyperpolarized mitochondria 
or increased mitochondrial membrane potential in the individ-
ual cells. Dot blot analysis of the data showed that the observed 
shift in rhodamine123 uptake was largely due to the appearance 
of a distinct population of yeast cells, which was increased in 
size in cells expressing both BimS and Bax as compared with 
Bax alone (Fig. 8 b). When BimS(1–88) or BimS∆∆ were co-
expressed with Bax, no enhancement of the Bax effect on mito-
chondrial membrane potential was seen (unpublished data). 
These data thus indicate a death-inducing effect of BimS in 
yeast cells, which depends on Bax but not on anti-apoptotic 
Bcl-2 proteins.
Discussion
In this study we analyzed molecular events during apopto-
sis induction by BimS. Although no evidence was found for 
binding of BimS to anti-apoptotic Bcl-2 proteins, we describe 
the mitochondrial translocation and insertion of BimS, which 
was suffi  cient to recruit and activate cytosolic Bax. Analysis 
of BimS mutants showed that apoptosis induction correlated 
with mitochondrial localization but not the ability to bind to 
Bcl-2. In yeast, BimS enhanced the death-inducing activity 
of Bax.
Surprisingly, high-level expression of BimEL failed to 
  induce apoptosis when expressed in cells stably carrying the 
  inducible construct. This may be a result of some experimental 
selection process (although the clones were established and se-
lected alongside the BimS clones), or expression of some post-
translational regulation mechanism that controls BimEL but not 
BimS. Only low levels of BimS are normally found in any cell 
that has been investigated. This is presumably linked to the fact 
that BimS is not subject to any post-translational regulation and 
is immediately active when expressed. Although it is conceiv-
able that the apoptosis-inducing activity of BimS is substantially 
different from that one of BimEL, there is little evidence to sug-
gest that. BimS contains the same BH3 domain and the same 
hydrophobic C terminus as the other major splice forms, 
whereas it lacks the DLC1-binding site and other parts of the 
longer forms. BimS was found to be, unlike the other forms, 
able to bind to Bax in certain detergents; however, a BH3 do-
main point mutant that had lost the ability to bind Bax was 
  unaltered in its capacity to induce apoptosis, indicating that this 
binding is not physiologically relevant (Marani et al., 2002; 
Willis et al., 2007). We also observed some binding of BimS to 
Bax in co-IP experiments. However, BimS(D69A) showed no 
Bax binding, confi  rming the view that this interaction is not 
  required for apoptosis induction by BimS.
When we investigated the association of BimS with mito-
chondria, some BimEL was also detected on mitochondria, and 
this fraction of BimEL was also inserted in the mitochondrial outer 
membrane (and presumably kept inactive by Bcl-2-like proteins). 
Furthermore, both BimEL and BimS were imported into isolated 
mitochondria. There seems no reason to assume that, once both 
are active, BimS acts in any way different from BimEL.
Bim can bind Bcl-2 and Bcl-2-like proteins very well, and 
it was therefore surprising to see that tet-induced BimS failed to 
do so in any detectable way. Perhaps there is the possibility that 
the amount of anti-apoptotic Bcl-2-like proteins that needs to be 
neutralized is so small as not to be detectable. However, there 
is no evidence to support this, and all models of interactions 
  between Bcl-2 family members are based on solidly detectable 
results. Importantly, when Bcl-2 was overexpressed to inhibit 
BimS-induced apoptosis, a direct interaction was seen. The data 
thus confi  rm the view that Bcl-2 blocks BH3-only protein-
  induced apoptosis by direct binding. However, BimS does not 
appear to induce apoptosis by binding to Bcl-2-like anti-apoptotic 
proteins. This conclusion is also supported by the analysis of 
mutants in either mitochondrial localization or BH3 domain, 
where apoptosis induction was strictly correlated with mitochon-
drial localization but not with the ability to bind Bcl-2 (Table I; 
a different BimS mutant that had lost the ability to bind Bcl-2 
but still induced apoptosis has been published previously [Marani 
et al., 2002]). Finally, in yeast, BimS enhanced the death-inducing 
Table I. Summary of Bcl-2 binding, localization, and apoptosis-inducing activity of BimS mutants
Proteins Localization Bcl-2 binding Apoptosis
BimS m yes yes
BimS∆∆ mn o n o
BimS(L64A) n.d. no no
BimS(R66E) m* yes no
BimS(D69A) m no yes
BimSTom5 m yes yes
BimS∆∆Tom5 m no no
BimS(1-88) c yes no
n.d., not determined; m, mitochondria; c, cytosol. *, data not shown.MITOCHONDRIAL IMPORT OF BIM • WEBER ET AL. 633
activity of Bax, in the bona fi  de absence of Bcl-2-like proteins. 
Although each of these fi  ndings on its own may have their limi-
tations, in their sum they strongly suggest that Bax activation 
and apoptosis by BimS occurs in the absence of binding to anti-
apoptotic Bcl-2 proteins.
Although Bax can be demonstrated to be bound to Bcl-2-
like proteins in some detergents (Hsu and Youle, 1997), it is 
diffi  cult to know how much of this interaction is physiological. 
The displacement model of BH3-only protein function predicts 
that Bax is bound to Bcl-2 until this interaction is broken up by 
BH3-only proteins (leaving aside for the moment the question 
of different localization; [Willis et al., 2007]). We tested the 
  interaction between Bax and Bcl-2-like proteins by Bax-IP in 
lysates of mitochondria containing 1% Triton X-100 (which 
allows co-IP of Bax and Bcl-2). Some Bcl-2 was coprecipitated; 
the amount of Bcl-xL was greater (as reported [Hsu and Youle, 
1997]), and some Mcl-1 was co-IPed as well (Fig. S3 b). There 
was no clear evidence of a BimS-dependent reduction of these 
interactions. However, the evidence is probably not conclu-
sive because much more Bax is found on mitochondria upon 
BimS induction.
Importantly, Bak has been found to be sequestered by 
Mcl-1 and Bcl-xL, and an elegant model has been proposed how 
Bcl-xL and Mcl-1 could restrain Bak and stop it from auto-
  activating (Willis et al., 2005). Very recently, predictions of both 
models of BH3-only function have been put to the test, and nei-
ther model has come away unscathed. The direct activation 
model has it that no Bax/Bak dependent apoptosis can occur in 
the absence of activator BH3-only proteins, but taking away 
these proteins led either only to a reduction of apoptosis (Kim 
et al., 2006) or had no effect (Willis et al., 2007). The Bak 
auto-activation proposed by the replacement model has also 
been queried because mutants of Bax and Bak that have lost 
Figure 7.  BimS accelerates the growth inhibiting effect of Bax in yeast. 
Yeast strains containing BimS, Bax, or Bax/BimS were grown in the pres-
ence or absence of tetracycline (to induce Bax expression) as indicated. An 
untransformed yeast strain was used as control. After periods of 24–30 h 
(a) or 48 h (b), OD600 was measured. Boxes indicate median and range 
of individual values (25 and 75% are the lower and upper box limits). 
Vertical bars on boxes indicate range of values, asterisks and circles 
indicate individual outliers. Statistical signiﬁ  cance was calculated using 
ANOVA and least square difference post-hoc tests. P values give levels 
of signiﬁ  cance.
Figure 8.  Bax expression causes mitochondrial hyperpolarization in 
yeast, and this effect is enhanced by BimS. Yeast strains containing BimS, 
Bax, or Bax/BimS were grown in the absence of tetracycline (to induce Bax 
expression) for 24 h. An untransformed yeast strain was used as control. 
Yeast cells were grown to an OD600 of 0.2 and incubated with 5 μM rho-
damine123 for 30 min at 30°C. Cells were analyzed by ﬂ  ow cytometry. 
(a) Histograms showing rhodamine123 ﬂ  uorescence. (b) Two-dimensional 
dot-plot of rhodamine123 versus forward scatter. Data are representative 
of six individual experiments.JCB • VOLUME 177 • NUMBER 4 • 2007  634
  detectable binding to anti-apoptotic Bcl-2-like proteins were 
functionally unaltered (Kim et al., 2006). In any case, although 
there is the possibility that Bax is also sequestered and kept in-
active by anti-apoptotic Bcl-2 proteins, it seems clear that the 
activation of Bax has to involve the additional step of mitochon-
drial translocation. Confl  icting results have been reported re-
garding the question which domain of Bax is important for this 
process (Priault et al., 2003; Schinzel et al., 2004; Cartron et al., 
2005), and Bax can permeabilize artifi  cial membranes in the 
absence of other proteins (Kuwana et al., 2002), suggesting that 
Bax is not regularly imported into mitochondria but uses an 
  alternative way of translocation. However, some signal must 
trigger this translocation. Although a peptide representing the 
BH3 domain of Bim (or Bid) can activate Bax (Letai et al., 
2002), high concentrations of peptide are required, and recent 
work shows that tethering Bid peptide to membranes strongly 
enhances its Bax-activating activity (Oh et al., 2006). Similarly, 
we detected no killing activity in BimS(1–88) (lacking the mito-
chondrial targeting domain), but substantial activity in BimSTom5 
(targeted to the outer mitochondrial membrane); the differences 
seen between studies using peptides and BH3-only protein may 
therefore simply be a matter of abundance.
The essential activity of BimS thus appears to be the acti-
vation of Bax. Although some interaction between the proteins 
can be demonstrated, mutant analysis shows that this detect-
able interaction is not required for apoptosis induction. Fur-
thermore, experiments by many investigators with chemical 
cross-linkers typically showed only dimeric and trimeric Bax 
on mitochondrial membranes, arguing against a complex con-
taining Bax and BH3-only proteins (although large complexes 
perhaps would go unnoticed). It is completely unclear how 
BimS conveys an activation signal to cytosolic Bax. Perhaps 
BimS causes changes to composition and topology of the outer 
mitochondrial membrane that will initiate an alteration in Bax. 
At least in most cells, some Bax is found on mitochondria, pos-
sibly in exchange and balance with cytosolic Bax. It seems 
therefore conceivable that the insertion of BimS into mitochon-
dria somehow affects mitochondrial Bax and removes it from 
the reaction, causing recruitment of Bax from the cytosol until 
a critical concentration is reached in mitochondria and Bax 
auto-activates.
A fi  nal point is the question whether the behavior we saw 
for Bim also holds true for other BH3-only proteins. Published 
studies, including analyses of gene-defi  cient mice, indicate that 
Bim, Bid, and Puma are the strongest apoptosis inducers within 
this group. This may be because, as suggested, the capacity 
of directly activating Bax (Letai et al., 2002) or their affi  nity for 
all anti-apoptotic Bcl-2 proteins rather than only a subset (Chen 
et al., 2005; Certo et al., 2006). However, another point can 
now be made for mitochondrial insertion. It has been noted 
  before that active Bid localizes to mitochondrial membranes 
(Grinberg et al., 2002; Esposti et al., 2003), and mitochondrial 
import of Bim was directly shown in this study. Of the other 
BH3-only proteins known, only Puma has a consensus mitochon-
drial tail-anchor sequence. A third possibility for the differing 
activity thus appears to be the ability to localize to mitochon-
drial membranes.
Materials and methods
Cell lines and protein induction
T-REx-293 cells transiently transfected with different mBimS mutants and 
T-REx-HeLa cell lines (Invitrogen) that stably express the tetracycline repres-
sor from the pCDNA6/TR vector were cultured in DME supplemented with 
10% fetal calf serum (Tet negative; PAA Laboratories), 5 μg/ml blasticidin, 
50 μg/ml gentamycin and 20 μg/ml vancomycin at 37°C/5% CO2. 
T-REx-HeLa cell lines stably expressing human hBimEL or murine mBimS were 
additionally supplemented with zeocin (125 μg/ml). Induction of mBimS 
mutant proteins was performed 7–24 h after electroporation of T-REx-293 
cells. For immunoprecipitation of BimS mutants, T-REx-293 cells were 
  cotransfected with a pEF-hBcl-2 construct (a gift from Dr. David Huang, 
Walter and Eliza Hall Institute for Medical Research, Victoria, Australia) or 
with pCDNA-hMcl-1 (a gift from Dr. Joseph Opferman, St. Jude Children’s 
  Research Hospital, Memphis, TN).
Generation of stable T-REx-HeLa cell lines
Stable T-REx-HeLa cell lines expressing mBimS protein were established 
  using pcDNA4 vectors coding for mBimS (see below) according to the 
manufacturer’s instructions (Invitrogen).
Construction of mBimS expression vectors
The genes coding for mBimS were ampliﬁ  ed by PCR and subcloned into 
the pcDNA4/TO/myc-HisA vector (Invitrogen) with a stop codon at the 
3-prime end to avoid transcription of the myc-His tag. For generation of the 
BimS-BH3 mutant proteins, the QuickChange II Site-Directed Mutagenesis 
kit (Stratagene) was used. C-terminal truncated BimS protein (BimS(1–88)) 
was obtained by PCR. Replacement of the C-terminal domain (aa 85–110) 
including the hydrophobic part of mBimS with the hydrophobic domain of 
the yeast Tom5 protein (aa 23–50) was performed by two-step PCR. 
mBimS∆∆Tom5 was generated using the same mutation strategy as above.
Subcellular fractionation
Cells were harvested in isotonic mitochondrial buffer (MB) (210 mM man-
nitol, 70 mM sucrose, 1 mM EDTA, and 10 mM Hepes [pH 7.5]) supple-
mented with 1× complete protease inhibitor cocktail (Roche) and the 
mitochondria were isolated as described earlier (Eskes et al., 2000) All 
fractions (membrane and soluble fractions) were stored in MB-EGTA buffer 
at −80°C until further analyses. Protein concentrations were determined by 
the Bradford assay in MB-EGTA-1% Triton buffer. Intracellular localization 
of Bim and Bax during induction of BimS in T-REx-HeLa cells or of BimS mu-
tants in T-REx-293 cells was analyzed by loading equal protein amounts of 
the membrane fraction and the soluble fraction on 12.5% SDS-PAA gels. 
Bim and Bax were detected with anti-Bim (Sigma-Aldrich) or anti-Bax anti-
bodies (clone 6A7; Upstate Biotechnology). A monoclonal 20E8 antibody 
against cytochrome c oxidase subunit IV (CoxIV; MoBiTec) and a monoclo-
nal antibody directed against caspase-8 (1C12 clone; Cell Signaling Tech-
nology) were used to detect marker proteins.
Insertion of Bax and mBimS into mitochondrial membranes
The insertion of Bax and BimS into the mitochondrial membrane during 
BimS induction was tested by alkali extraction of the mitochondrial pellets 
as described earlier (Eskes et al., 2000). The membranes were pelleted by 
centrifugation (260,000 g for 1 h at 4°C); proteins (the alkali-sensitive frac-
tion) were precipitated by 12% TCA and the corresponding volume of su-
pernatants and mitochondrial pellets were separated by SDS-PAGE.
Immunoprecipitation
Cells or isolated mitochondria were extracted in lysis buffer (50 mM Hepes 
[pH 7.5], 150 mM NaCl, 1 mM EDTA, 10% [vol/vol] glycerol, and 1% 
[vol/vol] Triton X-100) supplemented with a protease inhibitor cocktail for 
30 min on ice. The lysate was spun at 13.000 g for 10 min. For immuno-
precipitation of Bim, protein G–Sepharose beads were washed twice with 
lysis buffer followed by preincubation with monoclonal rat anti-Bim anti-
body (3C5 clone, a gift from Dr. Andreas Strasser, Walter and Eliza Hall 
Institute for Medical Research, Victoria, Australia) for 1 h at 4°C. As a con-
trol an antibody directed against mBmf (provided by Dr. Strasser) was 
used. The beads were incubated in the presence of 45–200 μg of proteins 
overnight with constant agitation at 4°C. After washing four times with 
  lysis/1% (vol/vol) Triton X-100 buffer (see above), bound protein was 
eluted off the beads by boiling in 2× Laemmli sample buffer and resolved 
by SDS-PAGE. Bax-IP was performed with 130 μg of mitochondria as de-
scribed by the manufacturer with a human-speciﬁ  c polyclonal Bax antibody 
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Detection of Bim, Bcl-2, Mcl-1, Bcl-w, A1, Bcl-xL, and Bax was done by West-
ern blotting using antibodies directed against Bim and Bax (see above). 
Bcl-2, Mcl-1 (clone 22), and Bcl-xL(clone 2H12) antibodies were from BD 
Biosciences; Bcl-w (clone 31H4) and A1 antibodies were from Cell Signal-
ing Technology.
Assays for apoptosis
After induction of BimS or BimS mutants, cells were washed in PBS before 
ﬁ  xation in 4% formaldehyde for 20 min at room temperature. Cells were 
washed in PBS and incubated in the presence of monoclonal anti-active-
caspase-3 antibody (BD Biosciences) in permeabilization buffer (0.5% 
[wt/vol] BSA and 0.5% [wt/vol] saponin in PBS). Cells were washed in 
permeabilization buffer and incubated with species-speciﬁ  c Cy3-conjugated 
secondary antibody (Dianova). Flow cytometry was performed using a 
FACSCalibur (Becton Dickinson).
Detection of Bax activation by cross-linking
Mitochondria were isolated from clone A2 6 h after tetracycline induction 
(control: untreated) and were incubated either with disuccinimidyl suber-
nate (DSS, Pierce Chemical Co.) or bis(sulfosuccinimidyl) subernate (BS
3; 
Pierce Chemical Co.) as decribed earlier (Eskes et al., 2000). Samples 
were directly dissolved in Laemmli sample buffer and then analyzed by 
Western blotting with an anti-Bax antibody (Clone 3; BD Biosciences).
Confocal microscopy
For localization of EGFP-Bax during BimS induction, BimS clone A2 was 
transiently transfected with an expression plasmid for EGFP-Bax (a gift from 
Dr. Christoph Borner, University of Freiburg, Freiburg, Germany). Cells 
were then seeded onto coverslips for overnight culture, and mitochondria 
were stained with MitoTracker Orange CMTMRos (Invitrogen) 30 min 
before washing with fresh media and tetracycline induction of BimS. To 
prevent detachment of cells, 25 μM of zVAD-fmk was added to block 
caspase-dependent apoptosis. Cells were ﬁ  xed in 3.7% formaldehyde for 
15 min, permeabilized with 0.1% Triton X-100 for 4 min, and blocked with 
5% heat-inactivated donkey serum for 10 min. Primary antibody incuba-
tions with rabbit anti-Bim (StressGen Biotechnologies) were performed for 
40 min, followed by incubation with secondary donkey anti–rabbit-Cy5 
antibody (1:150; Dianova) for 30 min. 0.5% BSA-PBS was used for block-
ing, antibody incubations, and wash steps, and coverslips were mounted 
in Mowiol.
For localization of BimS and BimS mutants, T-REx-293 cells were tran-
siently transfected with the respective expression plasmid, seeded onto cover-
slips and induced 7 h later for further 15 h with tet, stained for mitochondria, 
and processed as described. Cells were stained with rat anti-Bim (1:100, 
clone 3C5), followed by donkey anti–rat Alexa-488 (1:200; Invitrogen).
Cells were examined at room temperature with either a laser-
  scanning microscope (LSM 510 Axiovert 100M, 100×/1.3 oil immersion 
lens; Carl Zeiss MicroImaging, Inc.) or a confocal microscope  (TCS SP5, 
63×/1.2 water immersion lens; Leica) using the respective imaging medium. 
Pinholes were set to scan layers < 1μm, at a resolution of 1024 × 1024 
pixels. Acquired images were exported using the in-built Zeiss or Leica 
Image Browser, respectively. Adobe Photoshop was used to adjust image 
size and resolution, and to enhance contrast of the whole image for better 
visibility in some pictures.
In vitro mitochondrial import
Radiolabeled (
35S-Met) BimEL and BimS proteins were generated using the 
TNT reticulocyte transcription/translation system (Promega). Mitochondrial 
import experiments were performed essentially as described previously 
(Okamoto et al., 2002).
Analysis of cell death in yeast
The coding sequence of mouse Bax was ampliﬁ  ed by PCR and cloned into 
the tet-off plasmid pCM189 (Gari et al., 1997). Mouse BimS and BimS 
mutants were inserted into the constitutive-expression vector p415-ADH, 
  respectively (Mumberg et al., 1995). The plasmids were transformed into the 
S. cerevisiae strain EGY-48. Yeast cells were grown in SD medium contain-
ing 2% lactate and 1 μg/ml tetracycline. For induction of Bax, cells were 
shifted to medium without tetracycline (start at OD600 = 0.1). After  8 h, 
cultures were diluted to OD600 = 0.1 (no differences of growth were seen at 
this point in time between cultures), and culture was continued. OD600 was 
measured at indicated time points. Signiﬁ  cance of the observed differences 
was tested by ANOVA followed by the least square difference post-hoc test 
on data from independent experiments. For FACS analysis of the mitochon-
drial membrane potential, yeast cells were incubated with 5 μM rhoda-
mine123 for 30 min at 30°C in the dark. Subsequently, cells were   isolated 
by centrifugation, washed in PBS, and resuspended in PBS. Stained cells 
were immediately analyzed in a FACSCalibur cytometer (Becton Dickinson).
Online supplemental materials
Fig. S1 shows induction of apoptosis by tet-dependent BimS induction. 
Fig. S2 shows how Bcl-2 overexpression blocks BimS-induced   apoptosis 
in the A2 BimS clone. Fig. S3 describes interaction of Bax, BimS/BimS(D69A), 
and prosurvival Bcl-2-like proteins by IP. Fig. S4 shows subcellular local-
ization of Bax and BimS in the 3C4 BimS clone. Fig. S5 shows pro-
apoptotic activity of BimS and BimS mutants by Hoechst staining. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200610148/DC1.
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